Q4 net sales $336M (+3.2%); FY net sales $1.4B (+14.4%); FY22 guidance sales $1.525-1.60B

Ingevity Corp

2021-FY EPS reported $2.95 revenue$1,391,500,000

Q4 diluted EPS $0.74; adjusted EPS $0.78; FY diluted EPS $2.95 (includes $85M litigation charge impact of $1.63); adjusted EPS $5.23 (+7.2%).
FY adjusted EBITDA $422.2M (+6.1%), margin 30.3%; operating cash flow $293M, free cash flow $189.2M.
FY 2022 guidance: net sales $1.525-1.60B and adjusted EBITDA $430-460M.
EVP Michael P. Smith retiring March 1, 2022; consulting agreement through Feb 2024 with $1,000/day fee and stock-based compensation.

item 2.02 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael P. Smith

Executive Vice President and President, Performance Chemicals, Strategy and Business Development

NGVT · Ingevity Corp

Effective: 2022-03-01
Filed: February 23, 2022, 6:59 PM ET

Mr. Smith will retire from the Company, effective March 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael P. Smith retired as Executive Vice President and President, Performance Chemicals, Strategy and Business Development at Ingevity Corp.

Action: retired
Role: Executive Vice President and President, Performance Chemicals, Strategy and Business Development

Exact text from the filing

Mr. Smith will retire from the Company, effective March 1, 2022.

View on SEC.gov

Ingevity Corp filing history →

Source: SEC EDGAR

accession 0001653477-22-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.